Active Ingredient History

  • Now
Bevenopran is a peripherally acting μ-opioid receptor antagonist that also acts on δ-opioid receptors and was under development by Cubist Pharmaceuticals for the treatment of chronic opioid-induced constipation. It reached phase III clinical trials for this indication before being discontinued.   Wikipedia

  • SMILES: COc1cc(CNCCC2CCOCC2)ccc1Oc3cnc(cn3)C(=O)N
  • Mol. Mass: 386.45
  • ALogP: 2.28
  • ChEMBL Molecule:
More Chemistry
bevenopran | cb-5945 | cb5-945


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue